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Abstract
Background: Non-linear associations have been reported between baseline measures of
alcohol consumption and type 2 diabetes (T2DM). However, given that drinking varies
over the adult life course, we investigated whether differences existed in the longitudinal
trajectory of alcohol consumption according to T2DM status.
Methods: For a case–cohort (916 incident cases; 7376 controls) of British civil servants
nested within the Whitehall II cohort, the self-reported weekly volume of alcohol con-
sumption was traced backwards from the date of diagnosis or censoring to the beginning
of the study, covering a period of up to 28 years. Mean trajectories of alcohol intake were
estimated separately by diagnosis status using random-effects models.
Results: Drinking increased linearly among male cases before diagnosis, but declined
among male non-cases prior to censoring. At the time of diagnosis or censoring, con-
sumption among those who developed T2DM was 33.4 g/week greater on average.
These patterns were not apparent among women. Here, alcohol intake among female
cases was consistently below that of non-cases, with the difference in consumption most
pronounced around 15 years prior to diagnosis or censoring, at 28.0 g/week. Disparities
by diagnosis status were attenuated following adjustment for potential confounders,
including the frequency of consumption and metabolic factors. Drinking among male
and female cases declined following diagnosis.
Conclusions: Differences in the weekly volume of alcohol consumption are reported in
the years leading up to diagnosis or censoring. Although male and female cases predom-
inantly consumed alcohol at volumes lower than or equal to those who were not diag-
nosed, these disparities appear to be largely explained by a range of socio-demographic
and lifestyle factors. Where disparities are observed between cases and non-cases, ad-
justed absolute differences are small in magnitude. The decision to drink alcohol should
not be motivated by a perceived benefit to T2DM risk.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Background
Recent meta-analyses have reported dose–response rela-
tionships between the volume of alcohol consumption and
the risk of type 2 diabetes mellitus (T2DM).1,2 Specifically,
while increased risks of T2DM are evident at high volumes
of weekly consumption among both sexes, reductions in
risk at moderate volumes appear greatest among1 or en-
tirely specific to women.2 Aside from the volume con-
sumed, other dimensions of alcohol intake appear to be
important modifiers of effect. Though little studied to
date,3 there are a few indications that the risk of T2DM
may be lower at higher frequencies of weekly consumption
across both sexes, with both volume and frequency appear-
ing to operate independently of one another.4,5
However, despite indications that drinking behaviours
change across the life course,6 particularly among heavier
drinkers,7 with decreases in volume and increases in fre-
quency both observed with increasing age,6 studies of alco-
hol and T2DM risk have predominantly operationalized
drinking according to just a single measure of the volume
of alcohol consumption.2 Little is therefore known about
how longitudinal trajectories of alcohol consumption may
differ between participants who do and do not develop the
condition.
By exploring differences in the trajectory of alcohol con-
sumption according to the diagnosis of T2DM, we can
begin to develop a better understanding as to the validity
of different hypotheses concerning how increases or de-
creases in risk reported for different volumes of consump-
tion are likely to be conferred. These include the possibility
that risk may accumulate over time as a result of prolonged
heavy drinking, or during acute periods of the life course in
which sensitivity to the effects of alcohol consumption are
most pronounced.8 If the risk of T2DM accumulates as a
result of chronic heavy drinking, the trajectory of alcohol
consumption among those who develop T2DM would be
consistently or else predominantly higher on average than
among those that do not develop the condition.
In addition, with a growing number of studies linking
the onset of ill-health to a subsequent cessation or attenu-
ation of alcohol consumption,9–11 it is posited that partici-
pants who develop T2DM may exhibit a marked decline in
their consumption in line with gradual deterioration in
their health status prior to diagnosis.
To examine these hypotheses, this study estimates and
compares sex-specific trajectories of the total weekly vol-
ume of weekly alcohol consumption according to whether
or not participants were diagnosed with T2DM. In add-
ition, to explore changes to drinking behaviour following
diagnosis, a further analysis was also undertaken that ex-
tended the trajectory of alcohol intake beyond the date of
diagnosis.
Research design and methods
The Whitehall II study
The Whitehall II cohort was established in 1985 and en-
listed 10 308 (6895 male and 3413 female) civil servants
aged 35–55 years who worked in the offices of 20
Whitehall departments.12 Data were obtained at each
phase via a self-administered questionnaire, with a clinical
examination undertaken at every other phase. A fasting
plasma glucose test (FPG) was incorporated as part of the
clinical examination at phase three (1991–93), with subse-
quent screening then carried out at phases 5 (1997–99), 7
(2003–04), 9 (2007–09) and 11 (2012–13) alongside self-
administered questionnaires. The analytic sample was thus
defined as any participant free of T2DM at phase 3 and
who participated in at least one subsequent clinical exam-
ination such that their event status and follow-up time
could be determined.
Key Messages
• Little is known about how alcohol consumption differs throughout adulthood between those that do and do not de-
velop type 2 diabetes mellitus.
• This is the first study to report the mean trajectory of alcohol consumption by diagnosis status across up to 28 years
of follow-up.
• Little difference in consumption was apparent between cases and non-cases in the period leading up to diagnosis or
censoring after adjustment for confounding factors.
• The decision to drink alcohol should not be motivated by a perceived benefit to type 2 diabetes risk.
2 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyx274/4803218
by University of Cambridge user
on 15 February 2018
Assessment of alcohol consumption
Alcohol-consumption data were extracted from baseline
and all clinical phases noted above. At each phase, partici-
pants were asked to report the number of alcoholic drinks
they had consumed in the week prior to interview accord-
ing to ‘measures’ of spirits, ‘glasses’ of wine or ‘pints’ of
beer or cider. The study conservatively assumed 8 g of al-
cohol per measure of spirits or glass of wine and 16 g for
each pint of beer or cider. These measurements were then
summed to define the total volume of weekly alcohol con-
sumption. Robust standard errors were calculated as the
alcohol variable was positively skewed.
Assessment of T2DM
Self-reported measures of T2DM were documented at all
phases, defined as any self-reported doctor-diagnosis or
prescription of anti-diabetic medication. Given that close to
one-third of T2DM cases may be missed by self-reports,13
subjective measures were supplemented by objective data
from phase 3 onwards. Objective cases were identified at
each clinical examination following a minimum 5-hour fast,
defined according to a FPG test reading 7.0 mmol/L in line
with the 1998 World Health Organization (WHO) criteria.14
Covariates
BMI was selected as an indicator of adiposity and was cal-
culated using the conventional formula, with measures of
height and weight captured at each clinical examination.
Ethnicity was self-reported at phases 1 and 5 and coded as
‘White’, ‘South Asian’ or ‘other’. Family history of T2DM
(parent or sibling) was self-reported at phases 1 and 2.
Information regarding physical activity was ascertained via
a 20-item questionnaire that included questions on the fre-
quency and duration of participation in activities including
walking and cycling during the 4 weeks preceding each
phase. Participants were classified according to WHO
physical activity recommendations:15 meeting guidelines
(150 minutes of moderate-intensity exercise per week
or 75 minutes of vigorous-intensity activity); inactive
(<60 minutes of moderate physical activity and <60 mi-
nutes of vigorous physical activity; below guidelines (any-
one not inactive or meeting the WHO guidelines).
Smoking data were collected at each phase, with partici-
pants categorized according to whether they reported
being a current, former or never smoker. Finally, two indi-
cators of socio-economic status were also considered: last
known civil service occupational grade (administrative,
professional/executive, clerical/support) and employment
status (employed, retired, redundant/dismissed/sick/other).
Statistical analysis
Participants were grouped according to whether or not
they developed T2DM over the course of the study. Time
was scaled according to the date of diagnosis (for those
who developed T2DM) or the final date of participation
(for those who were censored), which were each coded as
year zero. The self-reported volume of alcohol consump-
tion was then traced backwards to the beginning of the
study for each participant. A follow-up time of –15 years
thus represents a measure of alcohol consumption collected
15 years prior to diagnosis or censoring, while a decennial
change coefficient reported in the results tables refers to
the change in alcohol consumption for every 10 years
closer to the date of diagnosis or censoring.
Mean trajectories of alcohol consumption by
diagnosis status
Linear trajectories of mean weekly alcohol consumption
were estimated for each group using the mixed-effects pack-
age (-mixed-) in Stata 13.16 Detailed information concerning
this process is included within Supplementary Appendices 1
and 2. Briefly, random-effects models were used to allow
each participant their own intercept and rate of change per
unit of time.
In addition to modelling linear trajectories of alcohol con-
sumption, a range of non-linear slopes were also explored by
subjecting the time variable to cubic and quadratic trans-
formation (time–3, time–2, time1, time2, time3). These trans-
formed variables were then included as predictors of alcohol
consumption both singularly and in pairs, permitting a broad
range of functional forms. The goodness-of-fit for each re-
sulting model was assessed using the Bayesian information
criterion (BIC), which penalizes analyses with a greater num-
ber of parameters, thereby helping to avoid any overfitting
the underlying data.17 An improvement in fit was defined as
any reduction in the BIC greater than or equal to a value of
10, relative to a linear random-effects model.18
After describing differences in mean alcohol-consump-
tion trajectories by diagnosis status, secondary analyses
were undertaken to assess the magnitude by which any dis-
parity between groups could be explained by an unequal
distribution of confounding factors. Confounding factors
were added incrementally and all models constrained to
the same analytical sample as the maximally adjusted
model, aiding the comparison of coefficients between mod-
els. Four models are reported: Model 1 (unadjusted);
Model 2 (as Model 1, plus adjustment for date of birth);
Model 3 (as Model 2, plus adjustment for consumption
frequency); and Model 4 (as Model 3, plus adjustment for
date of birth, BMI, employment status, ethnicity, family
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history of T2DM, occupational grade, physical activity
and smoking status). At each level of adjustment, the statis-
tical significance of differences in intercepts and rates of
change between case and non-case participants was as-
sessed via the inclusion of an interaction term between lin-
ear time and diagnosis status. Where repeated measures
were available, covariates were permitted to vary as a func-
tion of time.
Probability of transition to non-drinking;
sick-quitter effects
When estimating the mean trajectory of alcohol consump-
tion by diagnosis status, changes to the drinking compos-
ition of each group are not explicitly defined. For instance,
a downward mean trajectory may be indicative of either a
gradual overall decrease in the volume of consumption
among constituent drinkers or sudden transitions among
some participants to complete abstention. To shed light on
compositional changes within each mean trajectory, nested
logistic regression models were constructed for each group
to estimate the probability of transition to non-drinking
at each follow-up occasion. This was undertaken using the
-xtlogit- package in Stata 13.16
Predicted probabilities were then calculated using each
logistic regression model and plotted as a function of time.
To supplement these plots, a sensitivity analysis was under-
taken in which the main linear mixed-effects models were
re-run but restricted only to current drinkers (i.e. excluding
person-observations where zero consumption was re-
ported). Plotted trajectories within these supplementary
models may be considered more robust to the effect of
transitions to non-drinking, such as might be attributable
to the development of ill-health.
Changes to alcohol consumption before and
after diagnosis
To observe how drinking changes following the develop-
ment of T2DM, piecewise models were constructed. Using
the method described above, separate linear mixed-effects
models were constructed according to whether alcohol
consumption was reported before or after the documented
date of diagnosis. These piecewise models were adjusted
for age at the time of diagnosis to account for the possibil-
ity that any change following diagnosis may have been
confounded in part by advancing age.
Missing data
Sensitivity analyses were undertaken, which accounted for
instance where covariate data were missing due to unit (i.e. a
participant did not take part in an entire study phase) or
item non-response (i.e. a participant did not answer a given
question). Here, an imputation model was created using
chained equations.19 This predicted the most likely value of
each missing datum based upon observed covariates, and
thereby operated under the assumption that data were miss-
ing at random. Further information concerning the imput-
ation procedure is contained within Supplementary
Appendix 3. Results derived using imputed data did not dif-
fer markedly from those using complete-case data.
Results
Descriptive statistics
Of the 10 308 individuals originally enlisted at baseline, a
total of 8815 (85.5%) participated at phase 3. Among these,
226 prevalent cases were documented and thus excluded. A
total 5723 T2DM-free men and 2570 T2DM-free women
had a known incident diagnosis status and follow-up time.
After excluding person-observations recorded after the time
of diagnosis or censoring, alcohol-consumption data were
missing across 3.6% of person-observations. As shown in
Figure 1, this left an analytical sample of 5723 men and
2569 women, providing 27 711 and 11 734 observations, re-
spectively. Median follow-up measured 9.9 (IQR 4.1, 25.2)
years, with a maximum follow-up of 28.0 years among men
and 27.9 years among women. In total, 620 men and 296
women developed T2DM during follow-up.
Participants who developed T2DM had a worse risk
profile at baseline than those who did not develop the con-
dition (Table 1), with a greater proportion of such partici-
pants being physically inactive, of South Asian ethnicity, in
lower occupational grades and having a family history of
T2DM, higher BMI and older age. In terms of alcohol con-
sumption, women who developed T2DM reported a lower
volume of mean weekly alcohol consumption at baseline.
Trajectories of alcohol consumption up to the
date of diagnosis or censoring
A range of trajectories were explored, with fit statistics for
the corresponding models reported in Supplementary
Appendix 4. Trajectories among men and women who de-
veloped T2DM were best described as a linear function of
time. Conversely, of participants who were censored, a
non-linear trajectory provided the best fit of the underlying
data (Table 2 and Figure 2).
At 30 years prior to diagnosis or censoring, the mean vol-
ume of weekly alcohol consumption was estimated to be
roughly equivalent among cases and non-cases in men, at
around 80.0 g/week. However, by the time of diagnosis or
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censoring, the mean volume of weekly alcohol consumption
among men who did not develop T2DM was lower than
among men who developed the condition, at 92.6 g/week
and 126.0 g/week, respectively. This equated to a difference
of 33.4 g/week, or around 1.8 pints of 4.0% ABV lager.20
Among women, consumption remained consistently
higher among those that did not develop T2DM. Differences
in the mean volume of alcohol consumption by T2DM diag-
nosis were greatest at 15 years prior to the time of diagnosis
or censoring, at around 28.0 g/week. Differences were most
acute at both the beginning and end of the follow-up period,
equal to 13.3 g/week at the time of event or censoring, or
around 0.7 pints of 4.0% ABV lager.20
Multivariable-adjusted trajectories of alcohol
consumption up to the date of diagnosis or
censoring
As indicated in Table 1, T2DM risk factors were differen-
tially distributed between cases and non-cases. To test the
effect of confounder adjustment upon disparities in the tra-
jectory of consumption by T2DM status, models were in-
crementally adjusted for these covariates.
Results are reported in Table 3 and displayed in
Supplementary Appendix 5. Differences in consumption at
the time of diagnosis or censoring were attenuated among
men from 20.4 g/week (95% CI 8.9, 32.0) to 12.5 g/week
(95% CI 3.2, 21.8) following adjustment for confounding
factors, with disparity in the mean rate of change halved in
magnitude. Among women, differences in consumption at
the end of follow-up were also markedly reduced, falling
from 20.4 g/week (95% CI 14.0, 26.7) to 7.8 g/week (95%
CI 3.1, 12.4). There was no shift in the mean rate of
change over time.
Transitions to non-drinking
As shown in Figure 3, the probability of transition to ab-
stention was low among men regardless of diagnosis status
(p ¼ 0.934), with no difference between the two groups in
the probability of transition as a function of time (p for
interaction ¼ 0.123). Among women, the probability of
transition was consistently higher among female cases than
non-cases (p0.001), with no difference by diagnosis sta-
tus as a function of time (p for interaction¼0.630). When
person-observations with zero consumption were excluded
Figure 1. Derivation of the analytical sample.
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from the models reported in Table 3, differences by diag-
nosis status were little changed among both sexes
(Supplementary Appendix 6).
Trajectories of alcohol consumption beyond the
date of diagnosis
Of the 620 men and 296 women who developed
T2DM over the course of the study, 552 and 267 partici-
pants provided alcohol-consumption data after their
date of diagnosis. Trajectories of alcohol consumption
were estimated based upon a total 3262 person-
observations among men and 1513 person-observations
among women. Goodness-of-fit statistics for each piece-
wise model are reported in Supplementary Appendix 7.
Linear trajectories provided the best fit of the underlying
data and are reported in Table 4 and Figure 4. Significant
reductions in consumption were evident among both
sexes following diagnosis, equal to a mean 21.2 g/week per
decade among men and 4.5 g/week per decade among
women.
Conclusions
Recent meta-analyses have reported an increased risk of
T2DM among both sexes at higher volumes of average
daily1 or weekly2 alcohol consumption. Relative to indi-
viduals who did not develop T2DM, it was thus hypothe-
sized that those diagnosed with T2DM would exhibit a
consistently higher volume of alcohol consumption prior
to diagnosis. To test this hypothesis, random-effects mod-
els were constructed to examine differences in trajectories
of alcohol consumption by T2DM diagnosis.
Our findings do not support the supposition that the
risk of T2DM may accumulate as a consequence of
prolonged exposure to heightened volumes of alcohol.
Women diagnosed with T2DM consistently consumed
alcohol at volumes that were lower on average than
those who were censored, while men who developed
the condition consumed alcohol at lower or equivalent
volumes than non-cases until just a few years prior to
the end of the follow-up period. Although there is therefore
a possibility that an increased risk of T2DM may be con-
ferred among men as a consequence of acute heavy con-
sumption later in the life course—a period during which
sensitivity to the deleterious effects of higher alcohol-con-
sumption volumes may be most pronounced21–25—the
adjusted difference in consumption at this time was just
12.5 g/week, or around two-thirds of a 4.0% ABV pint of
lager per week.20
Consumption among female cases and non-cases was
consistently within the range of intake associated with re-
ductions in the risk of T2DM.2 At least two reasons for
this apparent contradiction are possible. First, the mean
trajectory for women who developed T2DM may have
comprised not primarily of persistent low-volume and
therefore lower-risk drinkers, but of higher-risk sick quit-
ters or former heavy drinkers who had attenuated their
drinking owing to poor health.11,26,27 This was supported
by the higher probability of transition to non-drinking
among female cases than non-cases (Figure 3), their worse
metabolic risk profile at baseline than those who were cen-
sored and attenuated reductions in T2DM risk as reported
elsewhere when former drinkers are excluded from non-
drinking reference categories.2,28,29 However, despite a
higher probability of transition to non-drinking among
female cases within the cohort, the exclusion of person-
observations where zero consumption was reported re-
sulted in an attenuation of differences by diagnosis status
(Supplementary Appendix 6). A second possibility was that
female reductions in T2DM risk associated with lower
volumes of alcohol2 may have been a statistical artefact
attributable to poor confounder adjustment, with 39% of
selected studies having only provided unadjusted or
age-adjusted risk estimates.2 As per results from recent
dose–response meta-analyses concerning alcohol consump-
tion and T2DM risk,1,2 there were clear sex-specific
disparities in the trajectories of alcohol consumption
Table 2. Trajectories of the mean volume of weekly alcohol
consumption from baseline until the end of follow-up, strati-
fied by sex and T2DM diagnosis
Best-fitting random-
effects models
g/week (95% CI) p-value
Men
T2DM (n 5 620)
Intercept 126.0 (115.2, 136.9) <0.001
Time1 15.2 (9.4, 21.0) <0.001
Censored (n55103)
Intercept 92.6 (89.6, 95.6) <0.001
Time1 –33.2 (–36.6, –29.8) <0.001
Time2 –1.3 (–1.4, –1.1) <0.001
Women
T2DM (n5296)
Intercept 27.8 (22.2, 33.4) <0.001
Time1 –0.2 (–4.1, 3.7) 0.919
Censored (n52273)
Intercept 41.1 (38.6, 43.6) <0.001
Time1 –15.9 (–19.0, –12.7) <0.001
Time2 –0.6 (–0.7, –0.4) <0.001
Intercept coefficients refer to the average volume of weekly alcohol con-
sumption at the time of diagnosis or censoring. Time coefficients refer to the
change in the average volume of weekly alcohol consumption per 10 years
closer to diagnosis or censoring. Superscript numbers for time refer to power
terms.
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prior to diagnosis. Understanding the determinants of
these differences is important and merits further detailed
investigation.
Drinking among male and female non-cases declined on
average during the decade preceding censoring. An analysis
of Whitehall II participants aged 61–85 years at phase 11
reported a broad range of reasons for participants reducing
their consumption into later life.30 Of the 40% who atte-
nuated their intake over the preceding decade, 21% of men
and 22% of women did so in response to illness or
pharmacological contraindication, and 45% of men and
34% of women as a health precaution. It is possible that
the downward trajectory among non-cases was a combin-
ation of such factors. Whatever the predominant motiv-
ation, the lack of a similar downward trajectory among
men who developed T2DM conflicts with the hypothesis
that declining health prior to the onset of T2DM would
elicit a reduction in consumption during a period preceding
diagnosis. Instead, when the trajectory was extended
among cases, reductions were apparent only after the date
of diagnosis. It is unclear whether this decline was a self-
motivated response to a deterioration in health or a reac-
tion to formal medical advice.
Study strengths and limitations
This is the first study to describe the trajectory of alcohol
consumption across the adult life course prior to T2DM
diagnosis. Analyses of the Whitehall II cohort benefitted
from six phases of observation, objective ascertainment of
T2DM cases and good coverage of the adult life course. In
addition, despite representing a geographically concen-
trated and occupationally narrow cohort, aetiological asso-
ciations within Whitehall II are consistent with those
Figure 2. Trajectories of the mean volume of weekly alcohol consumption until the end of follow-up, stratified by sex and T2DM diagnosis.
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reported from studies of general-population samples.31
Mean consumption reported by Whitehall II participants is
harmonious with nationally representative, UK-based co-
horts.6 However, analyses of Whitehall II data were de-
pendent upon self-reported measures of alcohol
consumption. Consequentially, plotted trajectories of
mean exposure risked being subject to some degree of re-
porting or recall bias.
A further limitation concerned the restriction of the
non-linear models to just two polynomial terms, which
constrained slopes to just one turning point. This con-
straint risked the plotted trajectories being simplistic if
multimodal curves were present within the underlying
data. However, based on results elsewhere,6 multimodal
trajectories appear unlikely. Moreover, while the iterative
addition of further polynomial terms can improve the
specification of statistical models, doing so comes at the
cost of diminished external validity.
Although this study included adjustment for a broad
range of demographic and lifestyle factors, two limitations
are noted. First, owing to the nutritional and metabolic ef-
fects of alcohol and alcoholic drinks, there is a possibility
that BMI may operate on the causal pathway between
drinking and T2DM. Unfortunately, research in this area is
conflicting. For instance, while Mendelian randomization
studies indicate a positive relationship between alcohol con-
sumption and markers of adiposity,32 it remains inconclu-
sive whether alcohol-derived calories are sufficiently
additive to meal-derived calories as to increase the risk of
metabolic disease in a clinically meaningful way.33,34 In
addition, at least one GWAS analysis indicates a negative as-
sociation between alcohol consumption and anthropometric
Figure 3. Probability of transition to non-drinking, stratified by sex and diagnosis status.
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measures,35 the longest-running alcohol-feeding experiment
to date shows no difference in weight change between
exposed and unexposed groups,36 and at least one ran-
domized–controlled trial reports that alcohol dosing affects
glycaemic traits similarly irrespective of body mass.37 Given
that the aim of this study was not to estimate the association
between a given level of consumption and T2DM risk, but
rather to predict changes in alcohol consumption over time,
an a priori decision was made to treat adiposity as a con-
founding factor. For reference, models are included in
Supplementary Appendix 8 that report multi-variable-ad-
justed linear trajectories of alcohol consumption with and
without the inclusion of BMI. Coefficients vary little, sug-
gesting that, if BMI is a mediator, its role in this particular
analysis is marginal.
A second issue concerned the possibility that non-alco-
hol-derived calories may represent a source of residual
confounding. Although a food-frequency questionnaire
was administered at each phase, dietary composition data
(e.g. fats, carbohydrates and fibre) were only derived in
Whitehall II for phases 3, 5 and 7, meaning that the inclu-
sion of diet-related variables would have necessitated a
substantial reduction in the analytical sample.
Aside from the issue of confounding, reverse causality
was possible among participants with fewer than three
person-observations. Among such individuals, the precise
ordering of changes to alcohol consumption and diabetes
status between two observations are unknown, with each
being documented concurrently at each phase of observa-
tion. Of the 916 individuals known to have developed
T2DM over the period of follow-up, 222 (24.2%) pro-
vided fewer than three person-observations, indicating that
close to one-quarter of known cases may have induced
changes to the alcohol-consumption trajectory. To assess
Figure 4. Piecewise age-adjusted trajectories of the mean volume of weekly alcohol consumption before and after the date of diagnosis, stratified by sex.
Table 4. Piecewise age-adjusted trajectories of the mean weekly volume of alcohol consumption before and after the date of
diagnosis, stratified by sex
Men Women
Piecewise models g/week (95% CI) p-value g/week (95% CI) p-value
Before the date of diagnosis
Intercepta 143.3 (117.3, 169.2) <0.001 32.6 (16.2, 49.0) <0.001
Time1b 15.3 (9.5, 21.1) <0.001 –0.2 (–4.1, 3.7) 0.925
After the date of diagnosis
Interceptc 103.6 (79.7, 127.5) <0.001 27.3 (12.2, 42.5) <0.001
Time1b –21.2 (–32.2, –10.3) <0.001 –4.5 (–7.9, –1.2) 0.008
aThe average volume of weekly alcohol consumption at the time of diagnosis.
bThe linear change in the average volume of weekly alcohol consumption per 10 years of follow-up.
cThe average volume of weekly alcohol consumption at the first phase of measurement following diagnosis. Models are adjusted for date of birth.
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this further, a sensitivity analysis was undertaken whereby
the maximally adjusted models reported in Table 3 were
restricted to participants with at least three person-
observations. Although not directly comparable due to
their differing samples, negligible difference in coefficients
is evident beyond an expected reduction in precision
(Supplementary Appendix 9), suggesting that our findings
are unlikely to be entirely due to reverse causation.
Finally, missing data were such that analyses may have
been applied to a healthier sub-sample of the source popula-
tion, impairing generalisability and potentially underesti-
mated the incidence of T2DM cases. For instance, Whitehall
II participants with unit or item non-response at any phase
during the period of follow-up exhibited a worse metabolic
profile at baseline than those with complete data
(Supplementary Appendices 10 and 11). However, results
based upon analyses of an imputed dataset were comparable.
Summary
Our findings do not support the notion that the harms or
alleged benefits of alcohol consumption for T2DM risk ac-
cumulate over time. Where differences were apparent by
diagnosis status, these were markedly attenuated following
adjustment for T2DM risk factors. Based upon results from
recent dose–response meta-analyses,1,2 differences were of
magnitudes that do not appear to be clinically important.
Given the absence of evidence indicating that mean con-
sumption was markedly higher among those diagnosed
with T2DM, the decision to take up drinking should not be
motivated by a perceived benefit to T2DM risk. Despite
suggestions that moderate drinking may be advantageous
for health,38 such advice seems premature in this context.
Indeed, taking a population perspective, some academics
recommend that drinking guidelines explicitly discourage
alcohol consumption for perceived health benefits.39 This
standpoint seems especially prudent given research which
indicates that adults who believe alcohol is beneficial for
their health drink alcohol in greater quantities than those
who do not or are unsure.40 Further research is now
required to better understand why trajectories of alcohol
consumption differ so markedly between men and women,
with more detailed analyses into how trajectories may differ
according to alternative dimensions of drinking behaviour.
Supplementary Data
The appendix is available as Supplementary data at IJE online.
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